FDA Determines Regulatory Review Period for M6-C Artificial Cervical Disc Patent Extension

Summary

The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the patent extension of M6-C Artificial Cervical Disc, following submissions to the US Patent and Trademark Office (USPTO) for patent extension.